Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ

Business

FILE PHOTO: Switzerland’s national flag flies in front of the logo of Swiss drugmaker Novartis in Basel, Switzerland, January 30, 2019. REUTERS/Arnd Wiegmann/File Photo

(Reuters) – Swiss drugmaker Novartis AG (NOVN.S) is nearing an agreement to acquire U.S. biotechnology firm The Medicines Co (MDCO.O) for about $7 billion, the Wall Street Journal reported on Saturday.

The deal, in which Novartis has agreed to pay $85 a share, could be announced this weekend, the Journal reported, citing people familiar with the matter.

Neither Novartis nor The Medicines Co were immediately available for comment on Saturday.

Reporting by Kanishka Singh in Bengaluru; editing by Jonathan Oatis

Products You May Like

Articles You May Like

IDF confirms ‘decline in forces’ in southern Gaza
Ukraine nuclear plant drone strike prompts warning over risks
Total solar eclipse plunges parts of Mexico into darkness
North America awed by total solar eclipse
MP targeted in Westminster honeytrap resigns party whip

Leave a Reply

Your email address will not be published. Required fields are marked *